Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Judith Peñafiel"'
Autor:
Oriol, Mitjà, Marc, Corbacho-Monné, Maria, Ubals, Andrea, Alemany, Clara, Suñer, Cristian, Tebé, Aurelio, Tobias, Judith, Peñafiel, Ester, Ballana, Carla A, Pérez, Pol, Admella, Núria, Riera-Martí, Pep, Laporte, Jordi, Mitjà, Mireia, Clua, Laia, Bertran, Maria, Sarquella, Sergi, Gavilán, Jordi, Ara, Josep M, Argimon, Gabriel, Cuatrecasas, Paz, Cañadas, Aleix, Elizalde-Torrent, Robert, Fabregat, Magí, Farré, Anna, Forcada, Gemma, Flores-Mateo, Cristina, López, Esteve, Muntada, Núria, Nadal, Silvia, Narejos, Aroa, Nieto, Nuria, Prat, Jordi, Puig, Carles, Quiñones, Ferran, Ramírez-Viaplana, Juliana, Reyes-Urueña, Eva, Riveira-Muñoz, Lidia, Ruiz, Sergi, Sanz, Alexis, Sentís, Alba, Sierra, César, Velasco, Rosa M, Vivanco-Hidalgo, Juani, Zamora, Jordi, Casabona, Martí, Vall-Mayans, Camila, González-Beiras, Bonaventura, Clotet, Esther, Diaz Soler
Publikováno v:
The New England Journal of Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de la UB
Universidad de Barcelona
New England Journal of Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
BackgroundCurrent strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy to prevent coronavirus di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791e4bc67140e052060e45a06d9cfd09
http://hdl.handle.net/2445/180762
http://hdl.handle.net/2445/180762
Autor:
Judith Peñafiel, Pilar Ricart, Cristina Tural, Laura Rodriguez, Anna Carreres, Ignacio Blanco, Ruth Lopez, Josep M. Llibre, Cristian Tebé, Josep Ferrer, Núria Pérez-Álvarez, Boris Revollo, Enrique Moret, Bonaventura Clotet, Joan Matllo, Sebastià Videla
Publikováno v:
Journal of Antimicrobial Chemotherapy
Autor:
Paz Cañadas, Ester Ballana, Esteve Muntada, Robert Fabregat, Rosa Maria Vivanco-Hidalgo, Clara Suñer, Josep M. Argimon, Juani Zamora, Ferrán Ramírez-Vilaplana, Maria Ubals, Pol Admella, Silvia Narejos, Pep Laporte, Gemma Flores-Mateo, Jordi Puig, Magí Farré, Sergi Gavilán, Carla A. Pérez, Martí Vall-Mayans, Andrea Alemany, Jordi Ara, Bonaventura Clotet, Marc Corbacho, Juliana Reyes-Urueña, Carles Quiñones, Sergi Sanz, Laia Bertran, Aleix Elizalde-Torrent, Jordi Casabona, Núria Riera-Martí, Alexis Sentís, Camila G-Beiras, Lidia Ruiz, Maria Sarquella, Núria Nadal, Cristina López, Judith Peñafiel, Anna Forcada, Eva Riveira-Muñoz, Cristian Tebé, Nuria Prat, César Velasco, Gabriel Cuatrecasas, Oriol Mitjà, Aurelio Tobias, Alba Sierra, Jordi Mitjà, Mireia Clua, Aroa N Gil-Ortega
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Background Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are limited to non-pharmacological interventions. Hydroxychloroquine (HCQ) has been proposed as a postexposure therapy to prevent Cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6be855301d8deb52cb8afce11811c8
https://doi.org/10.1101/2020.07.20.20157651
https://doi.org/10.1101/2020.07.20.20157651
Autor:
Lidia Ruiz, Núria Nadal, Jordi Ara, Laia Bertran, Paz Cañadas, Maria Sarquella, Carles Quiñones, Jordi Puig, Pol Admella, Anna Forcada, Aroa N Gil-Ortega, Gemma Flores-Mateo, Pep Laporte, César Velasco, Ferran Ramírez-Viaplana, Bonaventura Clotet, Marc Corbacho-Monné, Eva Riveira-Muñoz, Clara Suñer, Aurelio Tobias, Aleix Elizalde-Torrent, Josep M. Argimon, Jordi Casabona, Alba Sierra, Núria Riera-Martí, Alexis Sentís, Magí Farré, Camila G-Beiras, Ester Ballana, Cristian Tebé, Nuria Prat, Gabriel Cuatrecasas, Judith Peñafiel, Oriol Mitjà, Juliana Reyes-Ureña, Jordi Mitjà, Mireia Clua, Maria Ubals, Carla A. Pérez, Andrea Alemany, Sergi Gavilán, Martí Vall-Mayans, Robert Fabregat, Rosa Maria Vivanco-Hidalgo, Silvia Narejos, Esteve Muntada
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Digital.CSIC. Repositorio Institucional del CSIC
Clinical Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Digital.CSIC. Repositorio Institucional del CSIC
No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious for outpatients with COVID-19.
The authors thank Gerard Carot-Sans, PhD, for
The authors thank Gerard Carot-Sans, PhD, for
Autor:
Carles Quiñones, Ferrán Ramírez-Vilaplana, Maria Ubals, Robert Fabregat, Cristian Tebé, Marc Corbacho, Ester Ballana, Pol Admella, Bonaventura Clotet, Nuria Prat, Gabriel Cuatrecasas, Oriol Mitjà, Maria Sarquella, Alexis Sentís, Paz Cañadas, Andrea Alemany, Camila G-Beiras, Alba Sierra, Anna Forcada, Josep M. Argimon, Carla Álvarez, Sergi Gavilán, Aurelio Tobias, Martí Vall-Mayans, Esteve Muntada, Silvia Narejos, César Velasco, Jordi Puig, Judith Peñafiel, Lidia Ruiz, Aroa Nieto, Aleix Elizalde-Torrent, Núria Nadal, Pep Laporte, Magí Farré, Eva Riveira-Muñoz, Rosa Maria Vivanco-Hidalgo, Gemma Flores-Mateo, Jordi Mitjà, Mireia Clua, Jordi Ara, Laia Bertran, Clara Suñer, Juliana Reyes-Urueña, Jordi Casabona, Núria Riera-Martí
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Background: No therapeutics have yet been proven effective for the treatment of mild-illness caused by SARS-CoV-2. We assessed the efficacy and safety of hydroxychloroquine (HCQ) alone or in combination with cobicistat-boosted darunavir (DRVc) for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926ccf19a44b9bd4fd673e1540cfdbfd
http://hdl.handle.net/10261/217182
http://hdl.handle.net/10261/217182
Autor:
Judith Peñafiel, Miró Jm, Gatell Jm, M. A. Marcos, Juan Ambrosioni, José Luis Santiago Blanco, Christian Manzardo, M. M. Mosquera, Fernando Agüero, David Nicolás
Publikováno v:
Europe PubMed Central
OBJECTIVES The most recent guidelines suggest using integrase strand-transfer inhibitors (InSTIs) as the preferred antiretroviral regimens for naive HIV-infected individuals. However, resistance to InSTIs is not monitored in many centres at baseline.